Shares of Abbott Laboratories and Reckitt Benckiser fell Friday after a judge ruled a new trial could be heard involving a case on their infant formula products that had already seen a ruling in their ...

Back in October, a jury found North Chicago-based Abbott and Reckitt’s formula subsidiary Mead Johnson not responsible for a ...

The ruling overturned a previous verdict related to an infant formula case and has implications for both Abbott and Reckitt, ...

Bank of America raised Abbott Laboratories’ price target from $133 to $150, maintaining a buy rating on the stock. Other ...

The most recent trading session ended with Abbott (ABT) standing at $130.28, reflecting a -1.79% shift from the previouse trading day's closing. This change lagged the S&P 500's 0.49% gain on the day.

Abbott (ABT) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near ...

Abbott Laboratories’ stock has soared over 16% in three months, while the Dow Jones dipped 2% in the same period. Over the ...

Abbott (ABT) in October 2024 won the Whitfield case, though the plaintiffs appealed the Whitfield verdict and on Thursday, the judge granted a ...

Abbott Laboratories' (NYSE:ABT) stock is up by a considerable 21% over the past three months. Since the market ...

Bearish flow noted in Abbott (ABT) with 3,285 puts trading, or 2x expected. Most active are Mar-25 126 puts and Mar-25 127 puts, with total ...

Medtronic ( MDT -0.99%) and Abbott Laboratories ( ABT -1.91%) are two such examples in the healthcare industry. Both are ...

Analyse the historical data and Abbott Laboratories share price performance charts on this page. Our technical summary section provides analysis on Abbott Labs share price buy/sell indicators using ...